193 related articles for article (PubMed ID: 24806465)
1. Real-world efficiency of pharmacogenetic screening for carbamazepine-induced severe cutaneous adverse reactions.
Chen Z; Liew D; Kwan P
PLoS One; 2014; 9(5):e96990. PubMed ID: 24806465
[TBL] [Abstract][Full Text] [Related]
2. Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population.
Chang CC; Too CL; Murad S; Hussein SH
Int J Dermatol; 2011 Feb; 50(2):221-4. PubMed ID: 21244392
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.
Rattanavipapong W; Koopitakkajorn T; Praditsitthikorn N; Mahasirimongkol S; Teerawattananon Y
Epilepsia; 2013 Sep; 54(9):1628-38. PubMed ID: 23895569
[TBL] [Abstract][Full Text] [Related]
4. Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand.
Tiamkao S; Jitpimolmard J; Sawanyawisuth K; Jitpimolmard S
Int J Clin Pharm; 2013 Aug; 35(4):608-12. PubMed ID: 23649893
[TBL] [Abstract][Full Text] [Related]
5. Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China.
He XJ; Jian LY; He XL; Wu Y; Xu YY; Sun XJ; Miao LY; Zhao LM
Pharmacol Rep; 2013; 65(5):1256-62. PubMed ID: 24399721
[TBL] [Abstract][Full Text] [Related]
6. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.
Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Chen P; Lin SY; Chen WH; Konyoung P; Khunarkornsiri U; Auvichayapat N; Pavakul K; Kulkantrakorn K; Choonhakarn C; Phonhiamhan S; Piyatrakul N; Aungaree T; Pongpakdee S; Yodnopaglaw P
Epilepsia; 2010 May; 51(5):926-30. PubMed ID: 20345939
[TBL] [Abstract][Full Text] [Related]
7. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.
Hung SI; Chung WH; Liu ZS; Chen CH; Hsih MS; Hui RC; Chu CY; Chen YT
Pharmacogenomics; 2010 Mar; 11(3):349-56. PubMed ID: 20235791
[TBL] [Abstract][Full Text] [Related]
8. Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype.
Yuliwulandari R; Kristin E; Prayuni K; Sachrowardi Q; Suyatna FD; Menaldi SL; Wichukchinda N; Mahasirimongkol S; Cavallari LH
Pharmacogenomics; 2017 Dec; 18(18):1643-1648. PubMed ID: 29053440
[TBL] [Abstract][Full Text] [Related]
9. Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502?
Shi YW; Min FL; Qin B; Zou X; Liu XR; Gao MM; Wang Q; Zhou JQ; Liao WP
Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):58-64. PubMed ID: 22348435
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions.
Locharernkul C; Shotelersuk V; Hirankarn N
J Clin Neurosci; 2011 Oct; 18(10):1289-94. PubMed ID: 21802305
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
[TBL] [Abstract][Full Text] [Related]
12. Validation of a novel real-time PCR assay for detection of HLA-B*15:02 allele for prevention of carbamazepine - Induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in individuals of Asian ancestry.
Nguyen DV; Vidal C; Chu HC; Do NT; Tran TT; Le HT; Fulton RB; Li J; Fernando SL
Hum Immunol; 2016 Dec; 77(12):1140-1146. PubMed ID: 27544047
[TBL] [Abstract][Full Text] [Related]
13. HLA-B*15:02 association with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis.
Khor AH; Lim KS; Tan CT; Wong SM; Ng CC
Epilepsia; 2014 Nov; 55(11):e120-4. PubMed ID: 25266342
[TBL] [Abstract][Full Text] [Related]
14. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.
Chen P; Lin JJ; Lu CS; Ong CT; Hsieh PF; Yang CC; Tai CT; Wu SL; Lu CH; Hsu YC; Yu HY; Ro LS; Lu CT; Chu CC; Tsai JJ; Su YH; Lan SH; Sung SF; Lin SY; Chuang HP; Huang LC; Chen YJ; Tsai PJ; Liao HT; Lin YH; Chen CH; Chung WH; Hung SI; Wu JY; Chang CF; Chen L; Chen YT; Shen CY;
N Engl J Med; 2011 Mar; 364(12):1126-33. PubMed ID: 21428768
[TBL] [Abstract][Full Text] [Related]
15. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
Kulkantrakorn K; Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Prabmechai N; Vannaprasaht S; Chumworathayi P; Chen P; Sritipsukho P
Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
[TBL] [Abstract][Full Text] [Related]
16. HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.
Park HJ; Kim YJ; Kim DH; Kim J; Park KH; Park JW; Lee JH
Yonsei Med J; 2016 Jan; 57(1):118-26. PubMed ID: 26632391
[TBL] [Abstract][Full Text] [Related]
17. Association between the HLA-B alleles and carbamazepine-induced SJS/TEN: A meta-analysis.
Wang Q; Sun S; Xie M; Zhao K; Li X; Zhao Z
Epilepsy Res; 2017 Sep; 135():19-28. PubMed ID: 28618376
[TBL] [Abstract][Full Text] [Related]
18. Genetic predictors of Stevens-Johnson syndrome and toxic epidermal necrolysis induced by aromatic antiepileptic drugs among the Chinese Han population.
Wang W; Hu FY; Wu XT; An DM; Yan B; Zhou D
Epilepsy Behav; 2014 Aug; 37():16-9. PubMed ID: 24949577
[TBL] [Abstract][Full Text] [Related]
19. HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis.
Jaruthamsophon K; Tipmanee V; Sangiemchoey A; Sukasem C; Limprasert P
Sci Rep; 2017 Mar; 7():45553. PubMed ID: 28358139
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model.
Yuliwulandari R; Shin JG; Kristin E; Suyatna FD; Prahasto ID; Prayuni K; Mahasirimongkol S; Cavallari LH; Mitropoulou C; Patrinos GP; Hao J; Williams MS; Snyder SR
Pharmacogenomics J; 2021 Aug; 21(4):476-483. PubMed ID: 33824430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
